World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 79 1664 1515 46 37 442 29354

Jacques Fellay publications per year

The chart shows the history of publications by Jacques Fellay between 2001 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jacques Fellay published across 25 years, from 2001 to 2025, averaging 21.2 papers a year. Output peaked at 52 publications in 2021. 72 of the 530 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 2001 to 2025. Vertical axis: number of publications, 0 to 52. Peak 52 publications in 2021. 2001: 1 publication 2002: 4 publications 2003: 1 publication 2004: 3 publications 2005: 3 publications 2006: 5 publications 2007: 4 publications 2008: 4 publications 2009: 11 publications 2010: 28 publications 2011: 17 publications 2012: 12 publications 2013: 15 publications 2014: 20 publications 2015: 18 publications 2016: 16 publications 2017: 18 publications 2018: 38 publications 2019: 43 publications 2020: 48 publications 2021: 52 publications 2022: 50 publications 2023: 47 publications 2024: 35 publications 2025: 37 publications
2001 2025

530 publications in total across all disciplines

View publications per year as a table
Jacques Fellay: publications per year, 2001 to 2025
Year Publications
2001 1
2002 4
2003 1
2004 3
2005 3
2006 5
2007 4
2008 4
2009 11
2010 28
2011 17
2012 12
2013 15
2014 20
2015 18
2016 16
2017 18
2018 38
2019 43
2020 48
2021 52
2022 50
2023 47
2024 35
2025 37
Total 530
Download as CSV

Jacques Fellay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jacques Fellay sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 442–451 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 442 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31 442
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Jacques Fellay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques Fellay sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 78–79 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127 79
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Jacques Fellay is affiliated with the École Polytechnique Fédérale de Lausanne in Switzerland. Their research spans multiple fields centered on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology, with particular attention to infectious diseases, immunology, epidemiology, molecular biology, and genetics.

The scientist has contributed extensively to topics related to HIV research and treatment, HIV/AIDS research and interventions, and HIV-related health complications and treatments. Additional areas of focus include immune cell function and interaction, HIV/AIDS drug development and treatment, respiratory viral infections research, and genetic associations and epidemiology.

Fellay's recent scholarly output highlights a variety of studies concerning infectious diseases and immune responses, particularly in the context of COVID-19. Noteworthy publications include:

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 (2020, Science)
  • COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation (2020, Swiss Medical Weekly)
  • Human genetic and immunological determinants of critical COVID-19 pneumonia (2022, Nature)
  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection (2020, Cell)
  • Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption (2021, Nature Communications)

Frequent collaborators in their research include Huldrych F. Günthard, Enos Bernasconi, Roger D. Kouyos, Matthias Cavassini, and Alexandra Calmy. These co-authors have worked with Fellay on numerous studies, reflecting longstanding research partnerships.

Their work has been published repeatedly in several scholarly venues, with a significant presence in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • Zenodo (CERN European Organization for Nuclear Research)
  • The Journal of Experimental Medicine

Jacques Fellay's research contributions align with ongoing efforts to understand infectious diseases and immune mechanisms at genetic and molecular levels, underlining intersections between pathogen biology and host immune responses. Their studies often address critical public health questions pertaining to viral infections, immunity, and epidemiological strategies.

Best Publications

  • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

    Dongliang Ge;Jacques Fellay;Alexander J. Thompson;Jason S. Simon

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

    Alexander J. Thompson;Andrew J. Muir;Andrew J. Muir;Mark S. Sulkowski;Dongliang Ge

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

    Jacques Fellay;Alexander J. Thompson;Dongliang Ge;Curtis E. Gumbs

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Common genetic variation and the control of HIV-1 in humans.

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

  • IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C

    Thomas J. Urban;Alexander J. Thompson;Shelton S. Bradrick;Jacques Fellay

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

    Chantal Csajka;Catia Marzolini;Karin Fattinger;Laurent A. Décosterd

  • HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C

    Rasmi Thomas;Richard Apps;Ying Qi;Xiaojiang Gao

  • Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors.

    Etienne Patin;Milena Hasan;Jacob Bergstedt;Vincent Rouilly

  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.

    Jean-Laurent Casanova;Helen C. Su;Covid Human Genetic Effort

  • Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges

    Barbara Piasecka;Darragh Duffy;Alejandra Urrutia;Alejandra Urrutia;Helene Quach

  • Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction

    Alexander J. Thompson;Jacques Fellay;Keyur Patel;Keyur Patel;Hans L. Tillmann;Hans L. Tillmann

  • Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque

    Margalida Rotger;Judith Dalmau;Andri Rauch;Paul McLaren

  • Evidence of dysregulation of dendritic cells in primary HIV infection.

    Rachel Lubong Sabado;Rachel Lubong Sabado;Meagan O'Brien;Meagan O'Brien;Abhignya Subedi;Abhignya Subedi;Li Qin;Li Qin

  • Common Genetic Variation and the Control of HIV-1 in Humans

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

Frequent Co-Authors

Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
David Goldstein
David Goldstein University of New South Wales
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
Kevin V. Shianna
Kevin V. Shianna Duke University
Andri Rauch
Andri Rauch University of Bern
Matthias Cavassini
Matthias Cavassini University of Lausanne
Manuel Battegay
Manuel Battegay University Hospital of Basel
Dongliang Ge
Dongliang Ge Apostle Diagnostics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to various interdisciplinary career options, especially in healthcare and research. Many professionals in this field complement their Immunology background with advanced nursing degrees to enhance patient care in immunological disorders. For those interested in nursing, exploring the cheapest pmhnp programs can be a cost-effective way to specialize in psychiatric and mental health while integrating immunological insights.

Nurse practitioners with a Doctor of Nursing Practice degree can expect competitive compensation, as reflected in the dnp salary variations nationwide. This makes further education a valuable investment for Immunology professionals aiming to advance their clinical expertise.

For nurses looking to expand their scope, bridge options like the fnp to acute care np bridge program provide a seamless transition to acute care, enabling practitioners to work with immunocompromised patients in critical settings.

Additionally, accelerated routes through accelerated np programs offer a fast track to nursing practice, appealing to Immunology graduates seeking rapid entry into clinical roles. These pathways collectively highlight the dynamic nexus between Immunology education and advanced nursing careers.

Best Scientists Citing Jacques Fellay

Trending Scientists

Recently Published Articles